| Abbreviations | Meaning |
 | DS-TRIEL | Decision Support [cancer Clinical] Trial Eligibility |
| HRPC | Hormone-resistant Prostatic Cancer |
| ERMSA | Embryonal Rhabdomyosarcoma |
| PDA | Poorly Differentiated Adenocarcinoma |
| PDLL-D | Diffuse Poorly-differentiated Lymphocytic Lymphomas |
| CTR | Cardiothoracic Ratio; Carpal Tunnel Release; Central Tumor Registry; Connecticut Tumor Registry |
| M1 | Leukemia With Poorly Differentiated Myeloblasts [Franco-American-British (FAB) Classification] |
| BLV | Biological Limit Value; Blood Volume; Bovine Leukemia Virus |
| AMULV | Abelson Murine Leukemia Virus; Amphotrophic Murine Leukemia Virus |
| GCNST | Granular Cell Nerve Sheath Tumor |
| MTS | Multicellular Tumor Spheroid |
| HER-2 | Human Epidermal Growth Factor Receptor-2 [breast Cancer] |
| FSCCL | Follicular Small Cleaved Cell Lymphoma |
| TSA | Tumor Surface Antigen |
| SCCC | Squamous Cell Cervical Carcinoma |
Browse by Letter:
